Infinitopes Precision Immunomics
Infinitopes Precision Immunomics is an integrated cancer biotech company developing immunologically durable vaccines for multiple solid tumors. They combine precision antigen discovery platforms with high-efficiency vector delivery systems to identify and target tumor signatures accurately. Their lead vaccine candidate, ITOP1, is expected to begin phase I/IIa trials in Q3 2024.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: £12.8m
Date: 30-Apr-2024
Investors: Octopus Ventures, Cancer Research Horizons, Cancer Research Institute, CRIS Cancer Foundation, Kindred Capital, Manta Ray, Martlet Capital, Meltwind Advisory, Saras Capital, Wilbe Capital, expert angel investors
Markets: Biotechnology, Oncology, Immunotherapy, Cancer Vaccines, Biotechnology Research
HQ: Oxford, Oxfordshire, United Kingdom
Founded: 2021
Website: https://infinitopes.com
LinkedIn: https://www.linkedin.com/company/infinitopes
Crunchbase: https://www.crunchbase.com/organization/infinitopes
Leave a Comment
Comments
No comments yet.